Consumers are seeking out convenient and enjoyable formulas to support joint health and inflammation. Powders, shakes, shots, and ready-to-drink mixes are popular delivery formats in the category, however leading ingredients offering support may not always be conducive to novel delivery systems.
This dilemma led Pharmako Biotechnologies and its exclusive U.S. distributor and partner Gencor to develop innovative bioavailable formulas for the joint health and inflammation categories. In this interview, R.V. Venkatesh, managing director for Gencor, and Eric Meppem, director of Pharmako Biotechnologies, discuss the benefits of bioavailable HyrdoCurc curcumin, as well as Levagen and Levagen+ palmitoylethanolamide (PEA).
